Treatment of severe cutaneous adverse reaction with tocilizumab. Article uri icon

Overview

publication date

  • May 10, 2020

Research

keywords

  • Antibodies, Monoclonal, Humanized

Identity

PubMed Central ID

  • PMC7541614

Scopus Document Identifier

  • 85085028509

Digital Object Identifier (DOI)

  • 10.1111/bjd.19129

PubMed ID

  • 32291751

Additional Document Info

volume

  • 183

issue

  • 4